Safety Study of AX-5006 in Parkinson's Disease

We are investigating the safety of a new treatment called AX-5006 for people with and without Parkinson's disease. This research aims to understand how the agent affects different individuals.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre for Human Drug Research
Neurology
Oegstgeest, Netherlands
Sponsor: Axial Therapeutics Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.